Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
ID: 349868Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)" aimed at supporting interdisciplinary research that enhances awareness of the link between alcohol consumption and cancer risk. The initiative encourages applications that focus on changing social norms regarding alcohol use, developing and evaluating alcohol policy approaches, and implementing population-level interventions to mitigate alcohol-related cancer risks, particularly among underrepresented populations and those with alcohol use disorder. This funding opportunity is critical for addressing public health concerns, as alcohol consumption is a significant risk factor for cancer and can complicate treatment for affected individuals. Interested applicants can submit proposals starting January 5, 2024, with the first due date on February 5, 2024. For further information, applicants may contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at NIH Grants.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Institutes of Health (NIH), announces the funding opportunity titled "Population Approaches to Reducing Alcohol-related Cancer Risk" (R01 Clinical Trial Optional). This initiative seeks to promote interdisciplinary research aimed at improving awareness of the relationship between alcohol consumption and cancer risk, changing social norms related to alcohol, and developing interventions and policies to reduce this risk. Applications addressing varied consumption levels, particularly focusing on alcohol use disorder and underrepresented populations, are encouraged. Key details include a budget reflective of project needs and a project duration of up to five years. Applications can be submitted starting January 5, 2024, with the first set of due dates occurring on February 5, 2024. Investigators from diverse backgrounds are urged to apply, with an emphasis on adhering to strict application guidelines and timelines. The program underscores an urgent public health need, as alcohol consumption significantly increases cancer risk and can complicate treatment for cancer patients. Successful applications can greatly contribute to reducing alcohol-related cancer disparities and improving public health outcomes.
    Similar Opportunities
    Alcohol Health Services Research (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Alcohol Abuse and Alcoholism (NIAAA), has announced a funding opportunity titled "Alcohol Health Services Research (R34 Clinical Trial Optional)" (PAR-23-252). This initiative aims to address the treatment gap for individuals with Alcohol Use Disorder (AUD) by focusing on improving access to treatment, reducing stigma, examining cost structures, and implementing evidence-based approaches, particularly for health disparity populations. The total project budget is capped at $450,000 over a three-year period, and eligible applicants include higher education institutions, nonprofits, and government agencies, with a specific emphasis on those serving underrepresented communities. Interested parties should submit their applications electronically by October 16, 2023, with funding available until September 8, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Alcohol Health Services Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Institute on Alcohol Abuse and Alcoholism (NIAAA) for the Alcohol Health Services Research (R01 Clinical Trial Optional) grant. This initiative aims to address the treatment gap for individuals with Alcohol Use Disorder (AUD) by focusing on five key areas: increasing access to treatment, enhancing the appeal of treatment, examining cost structures and insurance systems, studying the dissemination and implementation of evidence-based approaches, and reducing health disparities among affected populations. The grant allows for a maximum budget of $500,000 and a project period of up to five years, with applications due by September 7, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    HIV Prevention and Alcohol (R34 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "HIV Prevention and Alcohol (R34 Clinical Trials Optional)" aimed at expanding the HIV/AIDS prevention toolkit among populations impacted by alcohol use. This grant seeks to support research that integrates effective prevention and treatment interventions while addressing the behavioral and biological risks associated with alcohol consumption, particularly among high-risk groups. The initiative is crucial for informing the design of future clinical trials focused on HIV prevention, with an anticipated funding amount of approximately $1.5 million for 2-4 awards. Interested applicants, including higher education institutions and community organizations, must submit their proposals by September 7, 2025, and can find additional information at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    HIV Prevention and Alcohol (R01 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "HIV Prevention and Alcohol (R01 Clinical Trials Optional)" aimed at expanding HIV prevention strategies among populations affected by alcohol use. This initiative encourages research projects that explore the relationship between alcohol consumption and HIV risk behaviors, focusing on areas such as Pre-exposure Prophylaxis (PrEP) utilization, Treatment as Prevention (TasP), and the integration of preventive intervention strategies. The program is particularly significant for addressing health disparities among high-risk groups, including men who have sex with men (MSM) and women with high-risk partners. The NIH anticipates funding between $2 million for 2 to 4 awards, with a project period of up to five years. Interested applicants can submit their proposals through the NIH ASSIST system or Grants.gov, and should direct inquiries to grantsinfo@nih.gov. The application deadline is May 7, 2026.
    Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)" aimed at advancing research in the treatment and recovery from alcohol use disorder (AUD). This grant supports clinical trials focusing on various aspects of AUD, including medication development, behavioral therapies, and innovative treatment technologies, particularly for populations facing health disparities. The funding is crucial for enhancing the understanding and efficacy of AUD treatments, ultimately contributing to improved public health outcomes. Eligible applicants can receive up to $500,000 in direct costs over a maximum project period of five years, with key submission deadlines on October 5, 2023, and February 5, 2024. For more information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-23-250.html.
    Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed), aimed at supporting investigator-initiated resources that enhance biomedical, behavioral, and social sciences research related to alcohol. This grant mechanism focuses on providing essential data, materials, and services to the broader alcohol research community, rather than supporting hypothesis-driven research, which should be submitted through other mechanisms. The NIH seeks to create high-quality resources that do not duplicate existing offerings, emphasizing the importance of diversity in research participation and encouraging applications from organizations serving underrepresented groups. Applications are due by January 25, 2024, and the project periods can last up to five years, with no cost-sharing or matching requirements. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)" aimed at supporting research on strategies to prevent and intervene in fetal alcohol spectrum disorders (FASD). The initiative seeks proposals that focus on reducing prenatal alcohol exposure and improving interventions for individuals affected by FASD, utilizing the Exploratory/Developmental Phased Award (R61/R33) mechanism, which allows for pilot studies in the initial phase and potential expansion in the subsequent phase based on milestone achievements. This funding is crucial for addressing significant public health challenges related to prenatal alcohol exposure, with a total award ceiling of $350,000 and no cost-sharing requirements. Interested applicants must submit their proposals by January 16, 2024, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov. For more details, visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-068.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for research projects focused on health equity related to tobacco, alcohol, and cannabis policies. This initiative aims to address disparities in exposure and use of these substances by examining new or adapted policies in the U.S., with the goal of advancing equitable health policies. The funding opportunity will utilize the R01 grant mechanism, which is optional for clinical trials, and is expected to open for applications in February 2025, with a funding ceiling of $499,999. Interested applicants should prepare their proposals in advance, as the NOFO is anticipated to be published in September 2024, and further details, including a pre-application webinar, will be announced following the publication.
    Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for pilot and exploratory research projects focused on health equity related to tobacco, alcohol, and cannabis use. The initiative aims to investigate disparities in exposure and usage of these substances by examining new or adapted policies in the U.S., with the goal of advancing equitable health policies. This funding opportunity will utilize the R21 grant mechanism, which supports early-stage research, and is expected to be published in September 2024, with the first application deadline in March 2025. Interested applicants should prepare their proposals in advance, as the estimated award date is December 1, 2025, and further details, including a pre-application webinar, will be announced following the NOFO publication.
    Comprehensive Alcohol Research Centers (P60 Clinical trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for Comprehensive Alcohol Research Centers (P60), aimed at fostering interdisciplinary research on Alcohol Use Disorder (AUD) and related issues. Applicants are required to establish a Dissemination Core to enhance community education and public health outreach, particularly focusing on underserved populations, while also incorporating a Plan for Enhancing Diverse Perspectives (PEDP) in their proposals. This initiative is crucial for advancing understanding and interventions related to alcohol misuse, with a total funding availability of up to $7 million for FY 2026. Interested organizations must submit their applications through Grants.gov by November 15, 2024, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.